Market Overview

JP Morgan Downgrades Hologic to Neutral

JP Morgan has downgraded Hologic (NASDAQ: HOLX) from Overweight to Neutral with a $20 price target.

Posted-In: JP MorganDowngrades Price Target Pre-Market Outlook Analyst Ratings

 

Related Articles (HOLX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional